Oxford University, SII tie-up delivers ‘high efficacy’ malaria vaccine

Oxford University, SII tie-up delivers ‘high efficacy’ malaria vaccine

[ad_1] London: A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up “high efficacy” malaria vaccine has been licensed for use in Ghana by Africa’s Food and Drugs Authority, the university announced here on Thursday. The R21/Matrix-M vaccine, leveraging Novavax’s adjuvant technology, has been approved for use in children aged…

Read More
Back To Top